Role of the locus coeruleus-norepinephrine system in arousal and circadian regulation of the sleep–wake cycle

Brain Norepinephrine: Neurobiology and Therapeutics

Volumn , Issue , 2007, Pages 157-195

  Aston Jones, Gary ^a   Gonzalez, Monica ^a   Doran, Scott ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932625408     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544156.007     Document Type: Chapter

References (226)

1. Seager, M. A., Johnson, L.D., Chabot, E. S., Asaka, Y. and Berry, S.D. Oscillatory brain states and learning: impact of hippocampal theta-contingent training. Proc. Natl. Acad. Sci. U. S. A., 99 (2002), 1616-1620.
2. Michel, F., Klein, M., Jouvet, D. and Valatx, J. L. Etude polygraphique du sommeil chez le rat. C. R. Seances Soc. Biol. Fil., 12 (1961), 2389-2391.
3. Timo-Iaria, C., Negrao, N., Schmidek, W. R. et al. Phases and states of sleep in the rat. Physiol. Behav., 5 (1970), 1057-1062.
4. Cespuglio, R., Calvo, J. M., Musolino, R. and Valatx, J. L. Phasic activity in rats. Physiol. Behav., 19 (1977), 589-596.
5. Steriade, M., McCormick, D. A. and Sejnowski, T. J. Thalamocortical oscillations in the sleeping and aroused brain. Science, 262 (1993), 679-685.
6. Obermeyer, W. H. and Benca, R. M. Effects of drugs on sleep. Neurol. Clin., 14 (1996), 827-840.
7. Thompson, P. M., Gillin, J. C., Golshan, S. and Irwin, M. Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence. Biol. Psychiatry, 38 (1995), 831-836.
8. Borbely, A. A., Tobler, I. andHanagasioglu, M. Effect of sleep deprivation on sleep and EEG power spectra in the rat. Behav. Brain Res., 14 (1984), 171-182.
9. Parmeggiani, P. L. Interaction between sleep and thermoregulation.Waking Sleep, 1 (1977), 123-132.
10. Aserinsky, E. and Kleitman, W. Regularly occurring periods of eye motility and concommitant phenomena during sleep. Science, 118 (1953), 273-274.
11. Jouvet, M., Michel, F. and Courjon, J. Sur un stade d'activité électrique cérébrale rapide au cours du sommeil physiologique. C. R. Seances Soc. Biol. Fil., 153 (1959), 1024-1028.
12. Jouvet, M. Recherches sur les structures nerveuses and les mécanismes responsables des différentes phases du sommeil physiologique. Arch. Ital. Biol., 100 (1962), 125-206.
13. Schmidt, M. H., Valatx, J. L., Schmidt, H. S., Wauquier, A. and Jouvet, M. Experimental evidence of penile erections during paradoxical sleep in the rat. NeuroReport, 5 (1994), 561-564.
14. Siegel, J. M. Brainstem mechanisms generatingREMsleep. In Principles and Practice of Sleep Medicine, ed. M. H. Kryer, T. Roth andW. C. Dement. (London: Saunders Company, 1994), pp. 125-144.
15. Moruzzi, G. andMagoun, H.W. Brain stem reticular formation and activation of the EEG. Electroencephalogr. Clin. Neurophysiol., 1 (1949), 455-473.
16. Aston-Jones, G., Chiang, C. and Alexinsky, T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog. Brain Res., 88 (1991), 501-520.
17. Denoyer, M., Sallanon, M., Kitahama, K., Aubert, C. and Jouvet, M. Reversibility of para-chlorophenylalanine-induced insomnia by intrahypothalamic microinjection of L-5-hydroxytryptophan. Neuroscience, 28 (1989), 83-94.
18. Hungs, M. and Mignot, E. Hypocretin/orexin, sleep and narcolepsy. Bioessays, 23 (2001), 397-408.
19. Jones, B. E. Arousal systems. Front. Biosci., 8 (2003), S438-S451.
20. Lin, J. S., Sakai, K. and Jouvet, M.Hypothalamo-preoptic histaminergic projections in sleepwake control in the cat. Eur. J. Neurosci., 6 (1994), 618-625.
21. McCormick, D. A. Neurotransmitter actions in the thalamus and cerebral cortex. J. Clin. Neurophysiol., 9 (1992), 212-223.
22. Pace-Schott, E. F. and Hobson, J. A. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat. Rev. Neurosci., 3 (2002), 591-605.
23. Sallanon, M., Denoyer, M., Kitahama, K. et al. Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuroscience, 32 (1989), 669-683.
24. Semba, K.Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance. Behav. Brain Res., 115 (2000), 117-141.
25. Aston-Jones, G. and Bloom, F. E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci., 1 (1981), 876-886.
26. Jacobs, B. L. andAzmitia, E. C. Structure and function of the brain serotonin system. Physiol. Rev., 72 (1992), 165-299.
27. Jones, B. E. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience, 40 (1991), 637-656.
28. Sakai, K. Neurons responsible for paradoxical sleep. In Sleep: Neurotransmitters and Neuromodulators, ed. W. A. Monti, J. M. Gaillard, and M. Radulovacki. (New York: Raven Press, 1985), pp. 405-429.
29. Vanni-Mercier, G., Gigout, S., Debilly, G. and Lin, J. S. Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav. Brain Res., 144 (2003), 227-241.
30. Gervasoni, D., Darracq, L., Fort, P. et al. Electrophysiological evidence that noradrenergic neurons of the rat locus coeruleus are tonically inhibited by GABA during sleep. Eur. J. Neurosci., 10 (1998), 964-970.
31. Gervasoni, D., Peyron, C., Rampon, C. et al. Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurons. J. Neurosci., 20 (2000), 4217-4225.
32. Kaur, S., Saxena, R. N. and Mallick, B. N. GABAergic neurons in prepositus hypoglossi regulate REM sleep by its action on locus coeruleus in freely moving rats. Synapse, 42 (2001), 141-150.
33. Lu, J., Bjorkum, A. A., Xu, M. et al. Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep. J. Neurosci., 22 (2002), 4568-4576.
34. Nitz, D. and Siegel, J. M. GABA release in the locus coeruleus as a function of sleep/wake state. Neuroscience, 78 (1997), 795-801.
35. Sherin, J. E., Elmquist, J. K., Torrealba, F. and Saper, C. B. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci., 18 (1998), 4705-4721.
36. McCarley, R.W. and Hobson, J. A. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science, 189 (1975), 58-60.
37. Sakai, K., Sastre, J. P., Kanamori, N. and Jouvet, M. State specific neurons in the pontomedullary reticular formation with special reference to the postural atonia during paradoxical sleep in the cat. In Brain Mechanisms of Perceptual Awareness and Purposeful Behavior, ed. O. Pompeiano and C. Ajmone Marsan. (New York: Raven Press, 1981), pp. 405-429.
38. Chase, M. H. and Morales, F. R. The atonia and myoclonia of active (REM) sleep. Annu. Rev. Psychol., 41 (1990), 557-584.
39. Sakai, K. Executive mechanisms of paradoxical sleep. Arch. Ital. Biol., 126 (1988), 239-257.
40. Sakai, K. and Koyama, Y. Are there cholinergic and non-cholinergic paradoxical sleep-on neurones in the pons? NeuroReport, 7 (1996), 2449-2453.
41. Hobson, J. A., McCarley, R.W. and Wyzinski, P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science, 189 (1975), 55-58.
42. Rasmussen, K., Morilak, D. A.andJacobs, B. L. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res., 371 (1986), 324-334.
43. Foote, S. L., Aston-Jones, G. and Bloom, F. E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl. Acad. Sci. U. S. A., 77 (1980), 3033-3037.
44. Rajkowski, J., Kubiak, P., Ivanova, S. and Aston-Jones, G. State related activity and reactivity of locus coeruleus neurons in behaving monkeys. In Catecholamines: Bridging Basic Science with ClinicalMedicine, ed. D. Goldstein, G. Eisenhofer and R.McCarty. (New York: Academic Press, 1998), pp. 740-744.
45. Rajkowski, J., Silakov, V., Ivanova, S. and Aston-Jones, G. Locus coeruleus neurons in monkey are quiescent in paradoxical sleep. Soc. Neurosci. Abstr., 23 (1997), 2130.
46. Rajkowski, J., Kubiak, P. and Aston-Jones, G. Locus coeruleus activity in monkey: phasic and tonic changes are associated with altered vigilance. Brain Res. Bull., 35 (1994), 607-616.
47. Doran, S., Rajkowski, J. and Aston-Jones, G. Locus coeruleus neurons in primate are active during waking but do not co-vary with arousal state. Activity across states of arousal. Soc. Neurosci. Abstr., (2003), Program No. 618.14.
48. Aston-Jones, G., Rajkowski, J. and Cohen, J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog. Brain Res., 126 (2000), 165-182.
49. Berridge, C.W. and Foote, S. L. Effects of locus coeruleus activation on electroencephalographic activity in the neocortex and hippocampus. J. Neurosci., 11 (1991), 3135-3145.
50. Berridge, C.W., Page, M. E., Valentino, R. J. and Foote, S. L. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience, 55 (1993), 381-393.
51. Berridge, C.W., Isaac, S.O. and Espana, R. A. Additive wake-promoting actions of medial basal forebrain noradrenergic α1-and β-receptor stimulation. Behav.Neurosci., 117 (2003), 350-359.
52. Jones, B. E., Harper, S. T. and Halaris, A. E. Effects of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine in the cat. Brain Res., 124 (1977), 473-496.
53. Lidbrink, P. The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat. Brain Res., 74 (1974), 19-40.
54. Roussel, B., Pujol, J. F. and Jouvet, M. Effects of lesions in the pontine tegmentum on the sleep stages in the rat. Arch. Ital. Biol., 114 (1976), 188-209.
55. Monti, J. M., D'Angelo, L., Jantos, H., Barbeito, L. and Abo, V. Effect of DSP-4, a noradrenergic neurotoxin, on sleep and wakefulness and sensitivity to drugs acting on adrenergic receptors in the rat. Sleep, 11 (1988), 370-377.
56. Laguzzi, R., Petitjean, F., Pujol, J. E. and Jouvet, M. Effects of intraventricular injection of 6-hydroxydopamine on sleep states and cerebral monoamines in cats. C. R. Seances Soc. Biol. Fil., 165 (1971), 1649-1653.
57. Matsuyama, S., Coindet, J. and Mouret, J. Intracisternal 6-hydroxydopamine and sleep in the rat. Brain Res., 57 (1973), 85-95.
58. Fritschy, J. M. and Grzanna, R. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience, 30 (1989), 181-197.
59. Jonsson, G., Hallman, H., Ponzio, F. and Ross, S. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)-a useful denervation tool for central and peripheral noradrenaline neurons. Eur. J. Pharmacol., 72 (1981), 173-188.
60. Hallman, H., Sundstrom, E. and Jonsson, G. Effects of the noradrenaline neurotoxin DSP 4 onmonoamine neurons and their transmitter turnover in rat CNS. J. Neural. Transm., 60 (1984), 89-102.
61. Logue, M. P., Growdon, J. H., Coviella, I. L. andWurtman, R. J. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. Life Sci., 37 (1985), 403-409.
62. Lyons, W. E., Fritschy, J. M.andGrzanna, R.Thenoradrenergic neurotoxinDSP-4eliminates the coeruleospinal projection but spares projections of the A5 and A7 groups to the ventral horn of the rat spinal cord. J. Neurosci., 9 (1989), 1481-1489.
63. Mogilnicka, E., Przewlocka, B., Van Luijtelaar, E. L., Klimek, V. and Coenen, A. M. Effects of REM sleep deprivation on central alpha 1-and β-adrenoceptors in rat brain. Pharmacol. Biochem. Behav., 25 (1986), 329-332.
64. Dooley, D. J., Bittiger, H., Hauser, K. L., Bischoff, S. F. andWaldmeier, P. C. Alteration of central alpha 2-and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin. Neuroscience, 9 (1983), 889-898.
65. Fety, R., Misere, V., Lambas-Senas, L. and Renaud, B. Central and peripheral changes in catecholamine-synthesizing enzyme activities after systemic administration of the neurotoxin DSP-4. Eur. J. Pharmacol., 124 (1986), 197-202.
66. Theron, C. N., de Villiers, A. S. and Taljaard, J. J. Effects of DSP-4 on monoamine and monoamine metabolite levels and on beta adrenoceptor binding kinetics in rat brain at different times after administration, Neurochem. Res., 18 (1993), 1321-1327.
67. Jaim-Etcheverry, G. and Zieher, L. M. DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats. Brain Res., 188 (1980), 513-523.
68. Gonzalez, M. M., Debilly, G. and Valatx, J. L. Noradrenaline neurotoxin DSP-4 effects on sleep and brain temperature in the rat. Neurosci. Lett., 248 (1998), 93-96.
69. Dement, W. C. The effect of dream deprivation. Science, 131 (1960), 1705-1707.
70. Mouret, J., Pujol, J. F. and Kiyono, S. Paradoxical sleep rebound in the rat. Effects of physical procedures involved in intracisternal injection. Brain Res., 15 (1969), 501-506.
71. Asikainen, M., Deboer, T., Porkka-Heiskanen, T., Stenberg, D. and Tobler, I. Sleep deprivation increases brain serotonin turnover in the Djungarian hamster. Neurosci. Lett., 198 (1995), 21-24.
72. Cramer, H., Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J. and Gessa, G. L. Stimulation of brain serotonin turnover by paradoxical sleep deprivation in intact and hypophysectomized rats. Brain Res., 54 (1973), 372-375.
73. Devi, R. S., Maheswari, K. S. and Namasivayam, A. Immunity and REM sleep deprivation. Med. Sci. Res., 22 (1994), 753-755.
74. Hery, F., Pujol, J. F., Lopez, M., Macon, J. and Glowinski, J. Increased synthesis and utilization of serotonin in the central nervous system of the rat during paradoxical sleep deprivation. Brain Res., 21 (1970), 391-403.
75. Mallick, B. N. and Thakkar, M. Short-term REM sleep deprivation increases acetylcholinesterase activity in the medulla of rats. Neurosci. Lett., 130 (1991), 221-224.
76. Pujol, J. F., Mouret, J., Jouvet, M. and Glowinski, J. Increased turnover of cerebral norepinephrine during rebound of paradoxical sleep in the rat. Science, 159 (1968), 112-114.
77. Sinha, A. K., Ciaranello, R.D., Dement, W. C. and Barchas, J.D.Tyrosinehydroxylase activity in rat brain following "REM" sleep deprivation. J. Neurochem., 20 (1973), 1289-1290.
78. Stern, W. C., Miller, F. P., Cox, R. H. and Maickel, R. P. Brain norepinephrine and serotonin levels following REM sleep deprivation in the rat. Psychopharmacologia, 22 (1971), 50-55.
79. D'Almeida, V., Hipolide, D. C., Azzalis, L. A. et al. Absence of oxidative stress following paradoxical sleep deprivation in rats. Neurosci. Lett., 235 (1997), 25-28.
80. Kovalzon, V. M. and Tsibulsky, V. L. REM-sleep deprivation, stress and emotional behavior in rats. Behav. Brain Res., 14 (1984), 235-245.
81. Porkka-Heiskanen, T., Smith, S. E., Taira, T. et al. Noradrenergic activity in rat brain during rapid eye movement sleep deprivation and rebound sleep. Am. J. Physiol., 268 (1995), R1456-R1463.
82. Fadda, P. and Fratta, W. Stress-induced sleep deprivation modifies corticotropin releasing factor (CRF) levels and CRF binding in rat brain and pituitary. Pharmacol. Res., 35 (1997), 443-446.
83. Abercrombie, E.D. and Jacobs, B. L. Single unit response of noradrenergic neurons in locus coeruleus of freelymoving cats I.Acutely presented stressful and nonstressful stimuli. J.Neurosci., 7 (1987), 2837-2843.
84. Bremner, J.D., Krystal, J. H., Southwick, S. M. and Charney, D. S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse, 23 (1996), 28-38.
85. Emoto, H., Tanaka, M., Koga, C. et al. Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain. Pharmacol. Biochem. Behav., 45 (1993), 419-422.
86. Shimizu, N., Nakane, H., Hori, T. andHayashi, Y. CRF receptor antagonist attenuates stressinduced noradrenaline release in the medial prefrontal cortex of rats. Brain Res., 654 (1994), 145-148.
87. Stanford, S. C. Central noradrenergic neurones and stress. Pharmacol. Ther., 68 (1995), 297-342.
88. Valentino, R. J., Foote, S. L. and Aston-Jones, G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res., 270 (1983), 363-367.
89. Gonzalez, M. M., Debilly, G., Valatx, J. L. and Jouvet, M. Sleep increase after immobilization stress: role of the noradrenergic locus coeruleus system in the rat. Neurosci. Lett., 202 (1995), 5-8.
90. Gonzalez, M. M., Valatx, J. L. and Debilly, G. Role of the locus coeruleus in the sleep rebound following two different sleep deprivation methods in the rat. BrainRes., 740 (1996), 215-226.
91. Rampin, C., Cespuglio, R., Chastrette, N. and Jouvet, M. Immobilisation stress induces a paradoxical sleep rebound in rat. Neurosci. Lett., 126 (1991), 113-118.
92. Kitahama, K. andValatx, J. L. Strain differences in amphetamine sensitivity in mice. II.Overcompensation of paradoxical sleep after deprivation in two C57 strains. Psychopharmacology (Berl), 66 (1979), 291-295.
93. Touret, M., Valatx, J. L. and Jouvet, M. The locus coeruleus: a quantitative and genetic study in mice. Brain Res., 250 (1982), 353-357.
94. Berger, B., Herve, D., Dolphin, A. et al. Genetically determined differences in noradrenergic input to the brain cortex: a histochemical and biochemical study in two inbred strains of mice. Neuroscience, 4 (1979), 877-888.
95. Edgar, D. M. and Seidel, W. F. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J. Pharmacol. Exp. Ther., 283 (1997), 757-769.
96. Dunn, A. J. and Berridge, C.W. Physiological and behavioral responses to corticotropinreleasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Brain Res. Rev., 15 (1990), 71-100.
97. Owens, M. J. and Nemeroff, C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev., 43 (1991), 425-473.
98. Merchenthaler, I. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides, 5 (1984), 53-69.
99. Valentino, R. J., Page, M., Van Bockstaele, E. and Aston-Jones, G. Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience, 48 (1992), 689-705.
100. Van Bockstaele, E. J., Colago, E. E. and Valentino, R. J. Corticotropin-releasing factorcontaining axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J. Comp. Neurol., 364 (1996), 523-534.
101. Valentino, R., Page, M. and Curtis, A. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res., 555 (1991), 25-34.
102. Chappell, P. B., Smith, M. A., Kilts, C.D. et al. Alterations in corticotropin-releasing factorlikeimmunoreactivity in discrete rat brain regions after acute and chronic stress. J.Neurosci., 6 (1986), 2908-2914.
103. Butler, P.D., Weiss, J. M., Stout, J. C. and Nemeroff, C. B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci., 10 (1990), 176-183.
104. Curtis, A. L., Lechner, S. M., Pavcovich, L. A. and Valentino, R. J. Activation of the locus coeruleus noradrenergic systemby intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmacol. Exp. Ther., 281 (1997), 163-172.
105. Rassnick, S., Sved, A. F. and Rabin, B. S. Locus coeruleus stimulation by corticotropinreleasing hormone suppresses in vitro cellular immune responses. J. Neurosci., 14 (1994), 6033-6040.
106. Butler, P., Weiss, J., Stout, J. and Nemeroff, C. B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the LC. J.Neurosci., 10 (1990), 176-183.
107. Rivier, C. L. and Plotsky, P. M.Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu. Rev. Physiol., 48 (1986), 475-494.
108. Rivier, J., Rivier, C. andVale, W. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science, 224 (1984), 889-891.
109. Britton, K. T., Lee, G., Vale, W., Rivier, J. and Koob, G. F. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res., 369 (1986), 303-306.
110. Emoto, H., Koga, C., Ishii, H. et al. A CRF antagonist attenuates stress-induced increases in NA turnover in extended brain regions in rats. Brain Res., 627 (1993), 171-176.
111. Heinrichs, S. C., Menzaghi, F., Pich, E. M. et al. Anti-stress action of a corticotropinreleasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology, 11 (1994), 179-186.
112. Krahn, D.D., Gosnell, B. A., Grace, M. and Levine, A. S. CRF antagonist partially reverses CRF-and stress-induced effects on feeding. Brain Res. Bull., 17 (1986), 285-289.
113. Diamant, M. and de Wied, D. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. Endocrinology, 129 (1991), 446-454.
114. Morimoto, A., Nakamori, T., Morimoto, K., Tan, N. and Murakami, N. The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats. J. Physiol., 460 (1993), 221-229.
115. Gonzalez, M. C. and Valatx, J. L. Effect of intracerebroventricular administration of alphahelical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus. J. Sleep Res., 6 (1997), 164-170.
116. Gonzalez, M. M. and Valatx, J. L. Involvement of stress in the sleep rebound mechanism induced by sleep deprivation in the rat: use of alpha-helicalCRH(9-41). Behav. Pharmacol., 9 (1998), 655-662.
117. Gonzalez, M. C. Role du locus coeruleus dans les mecanismes du rebond de sommeil chez le rat. Thèse de Neurosciences. Lyon: Universite Claude Bernard (1997).
118. Kupfermann, I. Hypothalamus and limbic system: peptidergique neurons, homeostasis, and emotional behavior. In Principles of Neural Science, ed. E. R. Kandel and J. H. Schwartz. (New York: Elsevier, 1991), pp. 735-749.
119. Charifi, C., Paut-Pagano, L., Debilly, G. et al. Effect of noradrenergic denervation of the amygdala upon recovery after sleep deprivation in the rat. Neurosci. Lett., 287 (2000), 41-44.
120. Dijk, D. J. and Edgar, D. M.Circadian and homeostatic control of wakefulness. In Regulation of Sleep and Circadian Rhythms, ed. F.W. Turek and P. C. Zee. (Basel:Marcel Dekker, 1999), pp. 111-147.
121. Rusak, B., Guido, M. and Semba, K. (2002) Immediate-early gene expression in the analysis of circadian rhythms and sleep. In Handbook of Chemical Neuroanatomy, ed. L. Kaczmarek and H. A. Robertson. New York: Marcel Dekker, Inc., pp. 147-170.
122. Abrahamson, E. E., Leak, R. K. and Moore, R. Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. NeuroReport, 12 (2001), 435-440.
123. Sun, X., Rusak, B. and Semba, K. Electrophysiology and pharmacology of projections from the suprachiasmatic nucleus to the ventromedial preoptic area in rat. Neuroscience, 98 (2000), 715-728.
124. Sun, X., Whitefield, S., Rusak, B. and Semba, K. Electrophysiological analysis of suprachiasmatic nucleus projections to the ventrolateral preoptic area in the rat. Eur. J. Neurosci., 14 (2001), 1257-1274.
125. Lu, J., Zhang, Y. H., Chou, T. C. et al.Contrasting effectsof ibotenate lesions of the parventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J. Neurosci., 21 (2001), 4864-4874.
126. Aston-Jones, G., Akaoka, H., Charlety, P. and Chouvet, G. Serotonin selectively attenuates glutamate-evoked activation of locus coeruleus neurons in vivo. J. Neurosci., 11 (1991), 760-769.
127. Aston-Jones, G. and Card, J. P. Use of Pseudorabies virus to delineatemultisynaptic circuits in brain: opportunities and limitations. J. Neurosci. Methods, 103 (2000), 51-61.
128. Chen, S., Ming, X., Miselis, R. andAston-Jones, G. Characterization of transsynaptic tracing with central application of Pseudorabies virus. Brain Res., 838 (1999), 171-183.
129. Aston-Jones, G., Chen, S., Zhu, Y. and Oshinsky, M. A neural circuit for circadian regulation of arousal. Nat. Neurosci., 4 (2001), 732-738.
130. Semba, J. I., Toru, M. and Mataga, N. Twenty-four hour rhythms of norepinephrine and serotonin in nucleus suprachiasmaticus, raphe nuclei, and locus coeruleus in the rat. Sleep, 7 (1984), 211-218.
131. Gonzalez, M. C., Lu, W. and Aston-Jones, G. Role of the noradrenergic locus coeruleus systeminsleep and waking circadian factors. Soc.Neurosci. Abstr., (2002), ProgramNo. 871.11.
132. Gonzalez, M. M., Zhu, Y. and Aston-Jones, G. Decrease in locus coeruleus-noradrenergic fiber staining under long-term constant darkness. Soc. Neurosci. Abstr., (2003), Program No. 930.17.
133. Kawakami, M., Yamaoka, S. and Yamaguchi, T. Influence of light and hormones upon circadian rhythm of EEG slowwaveandparadoxical sleep. In Advances in Climatic Physiology, ed. S. Itoh, K. Ogata and H. Yoshimura. (Tokyo: Igaken Shoin, 1972), pp. 349-366.
134. Elam, M., Yao, T., Svensson, T. H. and Thoren, P. Regulation of locus coeruleus neurons and splanchnic, sympathetic nerves by cardiovascular afferents. Brain Res., 290 (1984), 281-287.
135. Elam, M., Yao, T., Thorén, P. and Svensson, T. H.Hypercapnia and hypoxia: chemoreceptormediated control of locus coeruleus neurons and splanchnic, sympathetic nerves. BrainRes., 222 (1981), 373-381.
136. Morilak, D. A., Fornal, C. A. and Jacobs, B. L. Effects of physiological manipulations on locus coeruleus neuronal activity in freelymoving cats. I. Thermoregulatory challenge. Brain Res., 422 (1987), 17-23.
137. Morilak, D. A., Fornal, C. A. and Jacobs, B. L. Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. II. Cardiovascular challenge. Brain Res., 422 (1987), 24-31.
138. Morilak, D. A., Fornal, C. A. and Jacobs, B. L. Effects of physiological manipulations on locus coeruleus neuronal activity in freelymoving cats. III. Glucoregulatory challenge. Brain Res., 422 (1987), 32-39.
139. Valentino, R. J., Curtis, A. L., Page, M. E., Pavcovich, L. A. and Florin-Lechner, S. M. Activation of the locus coeruleus brain noradrenergic systemduring stress: circuitry, consequences, and regulation. Adv. Pharmacol., 42 (1998), 781-784.
140. Armitage, R., Trivedi, M., Hoffmann, R. and Rush, A. J. Relationship between objective and subjective sleep measures in depressed patients and healthy controls. Depress. Anxiety, 5 (1997), 97-102.
141. Benca, R., Obermeyer, W., Thisted, R. and Gillin, J. Sleep and psychiatric disorders: a metaanalysis. Arch. Gen. Psychiatry, 49 (1992), 651-668.
142. Armitage, R., Calhoun, J. S., Rush, A. J. and Roffwarg, H. P. Comparison of the delta EEG in the first and second non-REM periods in depressed adults and normal controls. Psychiatry Res., 41 (1992), 65-72.
143. Foster, F. G., Kupfer, D. J., Coble, P. andMcPartland, R. J. Rapid eyemovement sleep density. An objective indicator in severe medical-depressive syndromes. Arch. Gen. Psychiatry, 33 (1976), 1119-1123.
144. Kupfer, D. J., Ulrich, R. F., Coble, P. A. et al. Electroencephalographic sleep of younger depressives. Comparison with normals. Arch. Gen. Psychiatry, 42 (1985), 806-810.
145. Holsboer-Trachsler, E. and Seifritz, E. Sleep in depression and sleep deprivation: a brief conceptual review. World J. Biol. Psychiatry, 1 (2000), 180-186.
146. Ford, D. E. and Kamerow, D. B. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262 (1989), 1479-1484.
147. Lustberg, L. and Reynolds, C. F. Depression and insomnia: questions of cause and effect. Sleep Med. Rev., 4 (2000), 253-262.
148. Giles, D. E., Roffwarg, H. P., Rush, A. J. and Guzick, D. S. Age-adjusted threshold values for reduced REM latency in unipolar depression using ROC analysis. Biol. Psychiatry, 27 (1990), 841-853.
149. Ressler, K. J. and Nemeroff, C. B. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol. Psychiatry, 46 (1999), 1219-1233.
150. Roy, A., Pickar, D., De Jong, J., Karoum, F. and Linnoila, M.Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. Arch. Gen. Psychiatry, 45 (1988), 849-857.
151. Siever, L. J. and Davis, K. L. Overview: toward a dysregulation hypothesis of depression.Am. J. Psychiatry, 142 (1985), 1017-1031.
152. Habib, K. E., Weld, K. P., Rice, K. C. et al. Oral administration of a corticotropin-releasing hormonereceptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc. Natl. Acad. Sci. U. S. A., 97 (2000), 6079-6084.
153. Holsboer, F. Corticotropin-releasing hormone modulators and depression. Curr. Opin. Invest. Drugs, 4 (2003), 46-50.
154. Krueger, J. M. and Majde, J. A. Humoral links between sleep and the immune system: research issues. Ann. N. Y. Acad. Sci., 992 (2003), 9-20.
155. Steiger, A. Sleep and endocrinology, J. Intern. Med., 254 (2003), 13-22.
156. Tsuchiyama, Y., Uchimura, N., Sakamoto, T., Maeda, H. and Kotorii, T. Effects of hCRH on sleep and body temperature rhythms. Psychiatry Clin. Neurosci., 49 (1995), 299-304.
157. Benca, R. Mood disorders. In Principles and Practices of Sleep Medicine, ed. M. H. Kryger, T. Roth andW. C. Dement. (Philadelphia:W. B. Saunders Company, 2000), pp. 1140-1158.
158. Gillin, J. C., Buchsbaum, M., Wu, J., Clark, C. and Bunney, W., Jr. Sleep deprivation as a model experimental antidepressant treatment: findings from functional brain imaging. Depress. Anxiety, 14 (2001), 37-49.
159. Schreiber, W., Opper, C., Dickhaus, B. et al. Alterations of blood platelet MAO-B activity and LSD-binding in humans after sleep deprivation and recovery sleep. J. Psychiatr. Res., 31 (1997), 323-331.
160. Muller, H.U., Riemann, D., Berger, M.andMuller, W. E.The influence of total sleep deprivation on urinary excretion of catecholamine metabolites in major depression. Acta Psychiatr. Scand., 88 (1993), 16-20.
161. Lewis, D. A. and Morrison, J. H. Noradrenergic innervation of monkey prefrontal cortex: a dopamine-beta-hydroxylase immunohistochemical study. J. Comp. Neurol., 282 (1989), 317-330.
162. Aston-Jones, G., Rajkowski, J., Lu, W. et al. Prominent projections fromthe orbital prefrontal cortex to the locus coeruleus in monkey. Soc. Neurosci. Abstr., (2002), Program No. 86.9.
163. Rajkowski, J., Lu, W., Zhu, Y., Cohen, J. and Aston-Jones, G. Prominent projections from the anterior cingulate cortex to the locus coeruleus in Rhesus monkey. Soc. Neurosci. Abstr., (2000), Program No. 838.15.
164. Kessler, R. C., Berglund, P. A., Dewit, D. J. et al. Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario. Int. J. Methods Psychiatr. Res., 11 (2002), 99-111.
165. Gillin, J. C., Seifritz, E., Zoltoski, R. and Salin-Pascual, R. J. Basic science of sleep. In Comprehensive Textbook of Psychiatry, ed. B. J. Sadock. (Philadelphia: Lippincott Williams & Wilkins, 2000), pp. 199-208.
166. Saletu-Zyhlarz, G., Saletu, B., Anderer, P. et al. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology, 36 (1997), 117-129.
167. Charney, D. and Drevets, W. The neurobiological basis of anxiety disorders. In Neuropsychopharmacology: The Fifth Generation of Progress, ed. K. L. Davis, D. Charney, J. T. Coyle and C. Neroff. (Philadelphia: Lippincott Williams & Wilkins, 2002), pp. 901-930.
168. Weissman, M. M. Panic and generalized anxiety: are they separate disorders? J. Psychiatr. Res., 24 (1990), 157-162.
169. Aston-Jones, G., Ennis, M., Pieribone, V. A., Nickell, W. T. and Shipley, M. T. The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science, 234 (1986), 734-737.
170. Aston-Jones, G., Shipley, M. T., Chouvet, G. et al. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res., 88 (1991), 47-75.
171. Elam, M., Svensson, T. H. and Thorén, P. Locus coeruleus neurons and sympathetic nerves: activation by cutaneous sensory afferents. Brain Res., 366 (1986), 254-261.
172. Elam, M., Thorén, P. and Svensson, T. H. Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents. Brain Res., 375 (1986), 117-125.
173. Ordway, G. A., Klimek, V. and Mann, J. J. Neurocircuitry of mood disorders. In Neuropsychopharmacology: The Fifth Generation of Progress, ed. K. L. Davis, D. Charney, J. T. Coyle and C. Neroff. (Philadelphia: Lippincott Williams & Wilkins, 2002), pp. 1051-1064.
174. Coplan, J.D., Andrews, M.W., Rosenblum, L. A. et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. U. S. A., 93 (1996), 1619-1623.
175. Barros, M. and Tomaz, C. Non-human primate models for investigating fear and anxiety. Neurosci. Biobehav. Rev., 26 (2002), 187-201.
176. Davis, M. Anatomic and physiologic substrates of emotion in an animal model. J. Clin. Neurophysiol., 15 (1998), 378-387.
177. Harris, J. C. Experimental animal modeling of depression and anxiety. Psychiatr. Clin.North Am., 12 (1989), 815-836.
178. McKinney, W. T., Jr. and Bunney, W. E., Jr. Animal model of depression. I. Review of evidence: implications for research. Arch. Gen. Psychiatry, 21 (1969), 240-248.
179. Koob, G. F. and Heinrichs, S. C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res., 848 (1999), 141-152.
180. Newport, D. J. and Nemeroff, C. B. Neurobiology of posttraumatic stress disorder. Curr. Opin. Neurobiol., 10 (2000), 211-218.
181. Stein, D. J. Anxiety and stress disorders: course over the lifetime. In Neuropsychopharmacology: The Fifth Generation of Progress, ed. K. L. Davis, D. Charney, J. T. Coyle and C. Neroff. (Philadelphia: LippincottWilliams &Wilkins, 2002), pp. 859-866.
182. Hefez, A., Metz, L. and Lavie, P. Long-termeffects of extreme situational stress on sleep and dreaming. Am. J. Psychiatry, 144 (1987), 344-347.
183. Lavie, P. Sleep disturbances in the wake of traumatic events. New Engl. J. Med., 345 (2001), 1825-1832.
184. Geracioti, T.D., Jr., Baker, D. G., Ekhator, N. N. et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am. J. Psychiatry, 158 (2001), 1227-1230.
185. Mellman, T. A., Kumar, A., Kulick-Bell, R., Kumar, M. and Nolan, B. Nocturnal/daytime urine noradrenergic measures and sleep in combat-relatedPTSD. Biol.Psychiatry, 38 (1995), 174-179.
186. Yehuda, R., Southwick, S., Giller, E. L., Ma, X. and Mason, J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J. Nerv.Ment. Dis., 180 (1992), 321-325.
187. Heim, C. and Nemeroff, C. B. Neurobiology of early life stress: clinical studies. Semin. Clin. Neuropsychiatry, 7 (2002), 147-159.
188. Roozendaal, B. Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol. Learn. Mem., 78 (2002), 578-595.
189. Khan, A.U. Sleep REM latency in hyperkinetic boys. Am. J. Psychiatry, 139 (1982), 1358-1360.
190. O'Brien, L. M., Ivanenko, A., Crabtree, V. M. et al. Sleep disturbances in children with attention deficit hyperactivity disorder. Pediatr. Res., 54 (2003), 237-243.
191. Picchietti, D. L., England, S. J., Walters, A. S., Willis, K. and Verrico, T. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J. Child Neurol., 13 (1998), 588-594.
192. Picchietti, D. L., Underwood, D. J., Farris, W. A. et al. Further studies on periodic limbmovement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov. Disord., 14 (1999), 1000-1007.
193. Gruber, R., Sadeh, A. and Raviv, A. Instability of sleep patterns in children with attentiondeficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry, 39 (2000), 495-501.
194. Solanto, M.V. Clinical psychopharmacology of AD/HD: implications for animal models. Neurosci. Biobehav. Rev., 24 (2000), 27-30.
195. Solanto, M.V.Dopaminedysfunction inAD/HD:integrating clinical and basic neuroscience research. Behav. Brain Res., 130 (2002), 65-71.
196. Berridge, C.W. andWaterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev., 42 (2003), 33-84.
197. Hanna, G. L., Ornitz, E. M. and Hariharan, M. Urinary catecholamine excretion and behavioral differences in ADHD and normal boys. J. Child Adolesc. Psychopharmacol., 6 (1996), 63-73.
198. Oades, R.D., Daniels, R. and Rascher, W. Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder. Psychiatry Res., 80 (1998), 177-186.
199. Pliszka, S. R., Maas, J.W., Javors, M. A., Rogeness, G. A. and Baker, J.Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J. Am. Acad. Child Adolesc. Psychiatry, 33 (1994), 1165-1173.
200. Shekim, W.O., Bylund, D. B., Frankel, F. et al. Platelet alpha 2-adrenergic receptor binding to 3H-yohimbine and personality variations in normals. Psychiatry Res., 32 (1990), 125-134.
201. Shekim, W.O., Bylund, D. B., Hodges, K. et al. Platelet alpha 2-adrenergic receptor binding and the effects of d-amphetamine in boys with attention deficit hyperactivity disorder. Neuropsychobiology, 29 (1994), 120-124.
202. Shekim, W.O., Sinclair, E., Glaser, R. et al. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity. J. Child Neurol., 2 (1987), 50-56.
203. Spivak, B., Vered, Y., Yoran-Hegesh, R. et al. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta Psychiatr. Scand., 99 (1999), 300-304.
204. Trinh, J.V., Nehrenberg, D. L., Jacobsen, J. P., Caron, M. G. and Wetsel, W. C. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience, 118 (2003), 297-310.
205. Nofzinger, E. A. and Keshavan, M. Sleep disturbances associated with neuropsychiatric disease. In Neuropsychopharmacology: The Fifth Generation of Progress, ed. K. L. Davis, D. Charney, J. T. Coyle and C. Neroff. (Philadelphia: LippincottWilliams &Wilkins, 2002), pp. 1945-1959.
206. Czeisler, C. A., Dumont, M., Duffy, J. F. et al. Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet, 340 (1992), 933-936.
207. Dijk, D. J., Duffy, J. F., Riel, E., Shanahan, T. L. and Czeisler, C. A. Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. J. Physiol., 516 (1999), 611-627.
208. Iwanaga, K., Yamada, M., Wakabayashi, K., Ikuta, F. and Takahashi, H. A newly discovered age-related synaptic change in the human locus coeruleus: morphometric and ultrastructural studies. Acta Neuropathol. (Berl.), 91 (1996), 337-342.
209. Manaye, K. F., McIntire, D.D., Mann, D. M. and German, D. C. Locus coeruleus cell loss in the aging human brain: a non-random process. J. Comp. Neurol., 358 (1995), 79-87.
210. Tejani-Butt, S. M., Yang, J. and Zaffar, H. Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer's disease. Brain Res., 631 (1993), 147-150.
211. Coull, J. T. Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. [Review]. Drugs Aging, 5 (1994), 116-126.
212. Arnsten, A. F., Cai, J. X. and Goldman-Rakic, P. S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J. Neurosci., 8 (1988), 4287-4298.
213. Arnsten, A. F. T. and Goldman-Rakic, P. S. Alpha2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science, 230 (1985), 1273-1276.
214. Mabry, T. R., Gold, P. E. and McCarty, R. Age-related changes in plasma catecholamine and glucose responses of F-344 rats to a single footshock as used in inhibitory avoidance training. Neurobiol. Learn. Mem., 64 (1995), 146-155.
215. Mabry, T. R., Gold, P. E. and McCarty, R. Age-related changes in plasma catecholamine responses to acute swim stress. Neurobiol. Learn. Mem., 63 (1995), 260-268.
216. Mabry, T. R., Gold, P. E. and McCarty, R. Age-related changes in plasma catecholamine responses to chronic intermittent stress. Physiol. Behav., 58 (1995), 49-56.
217. Buysse, D. J. and Dorsey, C. M. Current and experimental therapeutics of insomnia. In Neuropsychopharmacology: The Fifth Generation of Progress, ed. K. L. Davis, D. Charney, J. T. Coyle and C. Neroff. (Philadelphia: Lippincott Williams & Wilkins, 2002), pp. 1931-1944.
218. Roehrs, T. A., Zorick, F. and Roth, T. Transient and short-terminsomnias. In Principles and Practices of Sleep Medicine, ed. M. H. Kryger, T. Roth and W. C. Dement. (Philadelphia: W. B. Saunders Company, 2000), pp. 624-632.
219. Morin, C. M., Rodrigue, S. and Ivers, H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom. Med., 65 (2003), 259-267.
220. Rodenbeck, A. and Hajak, G. Neuroendocrine dysregulation in primary insomnia. Rev. Neurol. (Paris), 157 (2001), S57-S61.
221. Vgontzas, A. N., Tsigos, C., Bixler, E.O. et al. Chronic insomnia and activity of the stress system: a preliminary study. J. Psychosom. Res., 45 (1998), 1-31.
222. Irwin, M., Clark, C., Kennedy, B., Christian Gillin, J. and Ziegler, M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Behav. Immun., 17 (2003), 365-372.
223. Hauri, P. Primary insomnia. In Principles and Practices of Sleep Medicine, ed. M. H. Kryger, T. Roth andW. C. Dement. (Philadelphia:W. B. Saunders Company, 2000), pp. 633-639.
224. Chiang, C. and Aston-Jones, G. Response of locus coeruleus neurons to footshock stimulation is mediated by neurons in the ventrolateral medulla. Neuroscience, 53 (1993), 705-715.
225. Lechner, S. M., Curtis, A. L., Brons, R. and Valentino, R. J. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res., 756 (1997), 114-124.
226. Page, M., Akaoka, H., Aston-Jones, G. and Valentino, R. Bladder distension activates locus coeruleus neurons by an excitatory amino acid mechanism. Neuroscience, 51 (1992), 555-563.